NEW YORK, Sept. 15 - ID Biomedical (Nasdaq: IDBE) of Vancouver said Friday that it had filed a patent infringement suit against Third Wave Technologies of Madison, Wis., for its use of a patented nucleic acid amplification and detection technology.

The Canadian company claimed that Third Wave’s Invader assay products and technology violate elements of US Patent 5,403,711, which is exclusively licensed to ID Biomedical.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.